Popular search terms:
Search Results
66 results found-
Current Clinical Trials at CSL Behring
CSL Behring conducts clinical trials for breakthrough medicines that treat hemophilia and other rare diseases. See our current clinical trials.
https://www.cslbehring.com/...ehring/current-clinical-trials -
Your Rights and Responsibilities | CSL Behring
CSL Behring's clinical trial subjects are entitled to specific rights. A clinical trial investigation must comply with a specific plan or protocol. Learn more.
https://www.cslbehring.com/...ur-rights-and-responsibilities -
Questions to Ask | CSL Behring
CSL Behring can provide you with a number of questions to ask the study investigator or coordinator before enrolling in a study. Learn more.
https://www.cslbehring.com/...ial/frequently-asked-questions -
Corporate Responsible Business Practice
OF OUR PRODUCTS 28 3.1 Bioethics 30 3.1.1 Research and development 30 3.1.2 Clinical trials 30 3.1.3 Stem cell research 31 3.1.4 Animal welfare 31 3.2 Adverse events 32 3.3
https://www.cslbehring.com/-/media/csl/documents/crbp-languages/csl_crbp17i_english.pdf -
What is a Clinical Trial?
CSL Behring's clinical trials are designed to test the efficacy of our latest breakthrough medicines. Find out how you can participate.
https://www.cslbehring.com/...hring/what-is-a-clinical-trial -
Research Practices
CSL Behring's clinical trials are carefully supervised, monitored, and documented in accordance with regulatory authorities. Learn more about how we conduct our research.
https://www.cslbehring.com/...csl-behring/research-practices -
2015 CSL Behring News Releases
FDA approval of flexible dosing for Hizentra is based on pharmacometrics (modeling and simulation). Clinical trials using these alternative Hizentra dosing regimens were not
https://www.cslbehring.com/-/media/shared/documents/news-release/news-release-archives/csl-behring-news-releases-2015.pdf -
Clinical Studies at CSL Behring
CSL Behring conducts clinical trials to ensure our products are safe and effective for our patients. Learn about our current clinical trials and breakthrough medicines.
https://www.cslbehring.com/...linical-studies-at-csl-behring -
2012 CSL Behring News Releases
attack has been shown to provide significantly faster relief to a patient (median onset of relief of 48 minutes in clinical trials, versus more than four hours in placebo group).
https://www.cslbehring.com/-/media/shared/documents/news-release/news-release-archives/csl-behring-news-releases-2012.pdf -
2016 CSL Behring News Releases
The most common adverse reactions in clinical trials were injection site reactions and headache. Data from PROLONG- 9FP were recently published in the American Society of
https://www.cslbehring.com/-/media/shared/documents/news-release/news-release-archives/csl-behring-news-releases-2016.pdf